Study Conduct

BMC selects PFS Clinical for trial coverage analysis

Wednesday, August 19, 2015

PFS Clinical, a Middleton, Wis.-based provider of turnkey administration solutions that address the key pain points of establishing and running a clinical trial office, has been engaged by the Boston Medical Center (BMC) Clinical Trial Office to provide Medicare Coverage Analysis (CA) of its research trials. PFS Clinical also is helping streamline the transfer of trial information into BMC’s recently deployed clinical trial management system (CTMS) and will provide employee training through its CA workshops.

[Read More]

Verified Clinical Trials inks two partner agreements

Thursday, August 13, 2015

AXIS Clinicals USA, a Dilworth, Minn.-based CRO, has partnered with the Verified Clinical Trials (VCT) national clinical trial database registry to stop attempts at dual enrollment in clinical trial research, thus preventing protocol deviations, improving data quality and promoting subject safety. Within the first seven days of use, the VCT system proved its worth by stopping a subject’s attempt at dual enrollment. VCT is the largest North American database registry in both early and late phase clinical trials.

[Read More]

Lundbeck joins Global Alzheimer’s Platform

Monday, August 10, 2015

Lundbeck, a global pharmaceutical company specializing in brain disorders, has joined the Global Alzheimer’s Platform (GAP) to help accelerate the development of new treatments for Alzheimer’s disease. GAP is a research initiative that aims to reduce the time and costs of Alzheimer’s disease clinical trials, develop an infrastructure that promotes innovation, and assure international collaboration on Alzheimer’s disease treatments.

[Read More]

Transparency Life Sciences assesses feasibility of decentralized patient data collection

Friday, August 7, 2015

Transparency Life Sciences, a clinical-stage drug development company based on open innovation, has enrolled its first patient in a new ulcerative colitis trial designed to assess the feasibility of replacing most conventional patient site visits with data collected using a combination of decentralized methods, including digital measurements, telemonitoring, remote video visits with clinical trial staff and blood collections by visiting nurses. In addition, the study is the first to allow key clinical endpoint assessments to be made by the subjects’ own gastroenterologists, rather than via designated sub-investigators affiliated with the trial.

[Read More]

Clincierge expands clinical concierge services for trial participants and families

Wednesday, July 29, 2015

Clincierge, a Philadelphia-based provider of specialized services and personalized support designed to overcome barriers to patient participation in clinical studies, expanded its patient concierge service into Cyprus. This is the 30th country where the company’s high-touch, one-on-one services for patients and families are available to aid companies conducting clinical trials increase trial enrollment and improve patient retention, thus helping to ensure that costly studies complete on time and on budget.

[Read More]

Society for Clinical Research Sites adds Covance as Global Impact Partner

Monday, July 6, 2015

The Society for Clinical Research Sites (SCRS), a global trade organization dedicated to representing the interests of clinical research sites, has announced a two-year partnership with Laboratory Corporation of America Holdings (LabCorp). Covance Drug Development will participate as a Global Impact Partner (GIP), a relationship designed to facilitate critical dialogue between industry stakeholders and clinical research sites.

[Read More]